Hubei Biocause Pharmaceutical Co., Ltd. operates in the Industrial organic chemicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hubei Biocause Pharmaceutical Co., Ltd. with three other
companies in this sector in China:
Zhejiang Jiaao Enprotech Stock Co Ltd
sales of 511.62 million Chinese Renmimbi [US$74.33 million]
JiangXi ChangJiu Biochemical Industry Company Limited
(542.31 million Chinese Renmimbi [US$78.79 million]
of which 96%
was Industry), and
Changmao Biochemical Engineering Co Ltd
(514.78 million Chinese Renmimbi [US$74.79 million]
of which 100%
was Sales of goods).
Hubei Biocause Pharmaceutical Co., Ltd. reported sales of 541.07 million Chinese Renmimbi (US$78.61 million)
December of 2015.
decrease of 32.9%
versus 2014, when the company's sales were 806.17 million Chinese Renmimbi.
Contributing to the drop in overall sales was the 52.4% decline
in Chemical Manufacturing, from 511.70 million Chinese Renmimbi to 243.56 million Chinese Renmimbi.
However, these declines were partially offset by the increase in sales of
Pharmaceutical Manufacturing (up 0.9% to 297.54 million Chinese Renmimbi)